Loading stock data…
USANA Health Sciences (USNA)
$21.01+0.31 (+1.50%)
Market ClosedLast close Jun 29
USANA Health Sciences, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
USANA Health Sciences, Inc. in the Consumer Defensive sector is trading at $21.01 with a market capitalization of $365M. Wall Street consensus targets $39.00 (1 analysts), implying a +85.6% move over the next 12 months. The stock is currently 45% below its 52-week high of $38.32, remaining 2.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +85.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $250.22M↑ | $226.20M↑ | $213.67M↓ | $235.85M↓ | $249.54M |
| Gross Profit | $190.78M↑ | $176.79M↑ | $164.85M↓ | $185.66M↓ | $197.09M |
| Operating Income | $13.87M↓ | $17.25M↑ | $1.22M↓ | $16.72M↑ | $15.67M |
| Net Income | $6.96M↑ | -$1.77M↑ | -$6.52M↓ | $9.65M↑ | $9.29M |
Peer Comparison
Fundamentals
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. Th...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$364.60M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.53%
Volume
Today's trading volume
110,944
Recent News
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Value Stocks to Buy as Lower Energy Costs Strengthen Market Outlook
Nexa Resources, Avnet, StoneCo and USANA Health stand out as lower oil prices ease inflation worries and boost the case for value stocks.
1 Small-Cap Stock Worth Investigating and 2 We Question
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
3 Reasons to Sell USNA and 1 Stock to Buy Instead
USANA currently trades at $18.88 per share and has shown little upside over the past six months, posting a small loss of 4.1%. The stock also fell short of the S&P 500’s 9% gain during that period.
Zacks.com featured highlights include StoneCo, USANA Health, Strategic Education, Nexa Resources and CVS
STNE, USNA, STRA, NEXA and CVS are highlighted as low price-to-book stocks with solid growth projections and strong value scores.